perfosfamide

DRUG2 trials

Sponsors

Barbara Ann Karmanos Cancer Institute, Memorial Sloan Kettering Cancer Center

Conditions

LymphomaMultiple Myeloma and Plasma Cell NeoplasmNeuroblastoma

Phase 2

Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma

CompletedNCT00002552

Barbara Ann Karmanos Cancer InstituteLymphoma, Multiple Myeloma and Plasma Cell Neoplasm

Start: 1993-10-31End: 2003-10-31Target: 40Updated: 2013-04-09

Chemotherapy, Radiation Therapy, Immunotherapy, and Bone Marrow Transplantation in Treating Patients With Neuroblastoma

CompletedNCT00002634

Memorial Sloan Kettering Cancer CenterNeuroblastoma

Start: 1995-02-28End: 2004-09-30Target: 45Updated: 2013-07-03

Related Papers

The anti-GD2 monoclonal antibody naxitamab plus GM-CSF for relapsed or refractory high-risk neuroblastoma: a phase 2 clinical trial

Nature Communications2025-02-1415 citations